WHO. Cervical cancer. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer.
Defossez G, Le Guyader-Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantonny E, et al. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 - Tumeurs solides : Étude à partir des registres des cancers du réseau Francim. Available from: https://www.santepubliquefrance.fr/import/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-tumeurs-solides-etude-a-partir. Cited 2024 Apr 2.
Lapôtre-Ledoux B, Remontet L, Uhry Z, Dantonny E, Grosclaude P, Molinié F, et al. Incidence des principaux Cancers en France Métropolitaine en 2023 et tendances depuis 1990. Bull Épidémiol Hebd. 2023;12–13:188–204.
Jansen EEL, Zielonke N, Gini A, Anttila A, Segnan N, Vokó Z, et al. Effect of organised cervical cancer screening on cervical cancer mortality in Europe: a systematic review. Eur J Cancer. 2020;127:207–23.
Pedersen K, Fogelberg S, Thamsborg LH, Clements M, Nygård M, Kristiansen IS, et al. An overview of cervical cancer epidemiology and prevention in Scandinavia. Acta Obstet Gynecol Scand. 2018;97(7):795–807.
Williams J, Rakovac I, Victoria J, Tatarinova T, Corbex M, Barr B, et al. Cervical cancer testing among women aged 30–49 years in the WHO European Region. Eur J Pub Health. 2021;31(4):884–9.
WHO. Complete cervical cancer profile sets. 2021. Available from: https://www.who.int/publications/m/item/cervical-cancer-country-profiles. Cited 2024 Apr 11
État des lieux et recommandations pour le dépistage du cancer du col de l’utérus en France. HAS; 2010. Available from: https://www.has-sante.fr/jcms/c_1009772/fr/etat-des-lieux-et-recommandations-pour-le-depistage-du-cancer-du-col-de-l-uterus-en-france.
Hamers F, Jezeweski-Serra D. Couverture du dépistage du cancer du col de l’utérus en France, 2012–2017. Revue de Biologie Médicale/N. 2020;353:67–74.
Levinson KL, Jernigan AM, Flocke SA, Tergas AI, Gunderson CC, Huh WK, et al. Intimate partner violence and barriers to cervical cancer screening: a gynecologic oncology fellow research network study. J Low Genit Tract Dis. 2016;20(1):47–51.
Article PubMed PubMed Central Google Scholar
Harder E, Juul KE, Jensen SM, Thomsen LT, Frederiksen K, Kjaer SK. Factors associated with non-participation in cervical cancer screening–a nationwide study of nearly half a million women in Denmark. Prev Med. 2018;111:94–100.
Grillo F, Vallée J, Chauvin P. Inequalities in cervical cancer screening for women with or without a regular consulting in primary care for gynaecological health, in Paris, France. Prevent Med. 2012;54(3–4):259–65.
Konopka AM, Barnay T, Billaudeau N, Sevilla-Dedieu C. Les déterminants du recours au dépistage du cancer du col de l’utérus: une analyse départementale. Econ Prév. 2019;2:43–63.
Ricardo-Rodrigues I, Jiménez-García R, Hernández-Barrera V, Carrasco-Garrido P, Jiménez-Trujillo I, de Andrés AL. Social disparities in access to breast and cervical cancer screening by women living in Spain. Public Health. 2015;129(7):881–8.
Article CAS PubMed Google Scholar
Petkeviciene J, Ivanauskiene R, Klumbiene J. Sociodemographic and lifestyle determinants of non-attendance for cervical cancer screening in Lithuania, 2006–2014. Public Health. 2018;156:79–86.
Article CAS PubMed Google Scholar
Guthmann JP, Pelat C, Parent du Chatelet I, Duport N, Lévy-Bruhl D, Institut de Veille Sanitaire (InVS). Déterminants socio-économiques de vaccination et de dépistage du cancer du col par frottis cervico-utérin (FCU). Analyse de l’Enquête santé et protection sociale (ESPS), 2012. 2014. Available from: https://www.santepubliquefrance.fr/determinants-de-sante/vaccination/documents/rapport-synthese/determinants-socio-economiques-de-vaccination-et-de-depistage-du-cancer-du-col-par-frottis-cervico-uterin-fcu-.-analyse-de-l-enquete-sante-et-prot.
Barré S, Massetti M, Leleu H, Catajar N, De Bels F. Caractérisation des femmes ne réalisant pas de dépistage du cancer du col de l’utérus par frottis cervico-utérin en France. Bull Epidémiol Hebd. 2017;2–3:39.
Sassenou J, Ringa V, Zins M, Ozguler A, Paquet S, Panjo H, et al. Women with obesity in cervical cancer screening. The double penalty: Underscreening and income inequalities. Obes Res Clin Pract. 2021;15(3):212–5.
Le Bihan-Benjamin C, Marchadier A, Audiger C, Khati I, Barré-Pierrel S. Quel déploiement du Programme national de dépistage organisé du cancer du col de l’utérus en France en 2022 ? Bull Épidémiol Hebd. 2024;5:82–91.
Bryere J, Dejardin O, Launay L, Grosclaude P, Launoy G, Réseau Français des regristres de cancers Francim. Environnement socioéconomique et incidence des cancers en France. Bull Épidémiol Hebd. 2017;4:68–77.
Traoré M, Vallée J, Chauvin P. Risk of late cervical cancer screening in the Paris region according to social deprivation and medical densities in daily visited neighborhoods. Int J Health Geogr. 2020;19(1):18.
Article PubMed PubMed Central Google Scholar
Kristensson JH, Sander BB, von Euler-Chelpin M, Lynge E. Predictors of non-participation in cervical screening in Denmark. Cancer Epidemiol. 2014;38(2):174–80.
Rondet C, Lapostolle A, Soler M, Grillo F, Parizot I, Chauvin P. Are immigrants and nationals born to immigrants at higher risk for delayed or no lifetime breast and cervical cancer screening? The results from a population-based survey in Paris metropolitan area in 2010. PLoS ONE. 2014;9(1):e87046.
Article PubMed PubMed Central Google Scholar
Enden MR, Møen K, Igland J, Diaz E. Trends in cervical cancer screening in Norway 2012–2017: a comparison study of non-immigrant and immigrant women. Scand J Public Health. 2024J;2:14034948231217636.
Bacal V, Blinder H, Momoli F, Wu KY, McFaul S. Is immigrant status associated with cervical cancer screening among women in Canada? Results from a cross-sectional study. J Obstet Gynaecol Can. 2019;41(6):824-831.e1.
Idehen EE, Koponen P, Härkänen T, Kangasniemi M, Pietilä AM, Korhonen T. Disparities in cervical screening participation: a comparison of Russian, Somali and Kurdish immigrants with the general finnish population. Int J Equity Health. 2018;17(1):56.
Article PubMed PubMed Central Google Scholar
Vahabi M, Lofters AK, Kopp A, Glazier RH. Correlates of non-adherence to breast, cervical, and colorectal cancer screening among screen-eligible women: a population-based cohort study in Ontario, Canada. Cancer Causes Control. 2021F;32(2):147–55.
Crampe-Casnabet C, Franck JE, Ringa V, Coeuret-Pellicer M, Chauvin P, Menvielle G. Role of obesity in differences in cervical cancer screening rates by migration history. The Constances survey. Cancer Epidemiol. 2019;58:98–103.
Sassenou J, Ringa V, Zins M, Ozguler A, Paquet S, Panjo H, et al. Combined influence of immigration status and income on cervical cancer screening uptake. Prev Med Rep. 2023;36:102363.
Article PubMed PubMed Central Google Scholar
Suivi et orientation des femmes enceintes en fonction des situations à risque identifiées. HAS; 2007. Available from: http://www.cfef.org/archives/bricabrac/suivigrossesse.pdf.
Eslier M, Azria E, Chatzistergiou K, Stewart Z, Dechartres A, Deneux-Tharaux C. Association between migration and severe maternal outcomes in high-income countries: Systematic review and meta-analysis. PLoS Med. 2023;20(6):e1004257.
Article PubMed PubMed Central Google Scholar
Eslier M, Deneux-Tharaux C, Sauvegrain P, Schmitz T, Luton D, Mandelbrot L, et al. Severe maternal morbidity among undocumented migrant women in the PreCARE prospective cohort study. BJOG. 2022;129(10):1762–71.
Blondel B, Coulm B, Bonnet C, Goffinet F, Le Ray C. National coordination group of the national perinatal surveys. Trends in perinatal health in metropolitan France from 1995 to 2016: results from the French national perinatal surveys. J Gynecol Obstet Hum Reprod. 2017;46(10):701–13.
Article CAS PubMed Google Scholar
Gonthier C, Estellat C, Deneux-Tharaux C, Blondel B, Alfaiate T, Schmitz T, et al. Association between maternal social deprivation and prenatal care utilization: the PreCARE cohort study. BMC Pregnancy Childbirth. 2017;17:126.
Article PubMed PubMed Central Google Scholar
Aranda E, Franck JE, Ringa V, Sassenou J, Coeuret-Pellicer M, Rigal L, et al. Social inequalities in participation in cancer screening: does the mode of data collection matter? The CONSTANCES cohort. European Journal of Public Health. 2021;31(3):602–8.
Lofters A, Vahabi M, Glazier RH. The validity of self-reported cancer screening history and the role of social disadvantage in Ontario, Canada. BMC Public Health. 2015;15(1):28.
Article PubMed PubMed Central Google Scholar
Anderson J, Bourne D, Peterson K, Mackey K. Evidence brief: accuracy of self-report for cervical and breast cancer screening. Washington (DC): Department of Veterans Affairs (US). 2019.
Lofters AK, Moineddin R, Hwang SW, Glazier RH. Does social disadvantage affect the validity of self-report for cervical cancer screening? Int J Womens Health. 2013;5:29–33.
Article PubMed PubMed Central Google Scholar
Moussier M. Réalisation du frottis cervico-utérin de rattrapage pendant la grossesse : profil des patientes concernées et informations reçues à propos du dépistage du cancer du col de l’utérus : étude observationnelle multicentrique dans le département des Alpes-Maritimes. 2019. Available from: https://dumas.ccsd.cnrs.fr/dumas-02271416/document. Cited 2020 Jul 22.
Saulneron M, Descamps-Mollier M, Carcopino X. Analyse de la pratique du frottis cervico-utérin de dépistage pendant la grossesse en France : étude bicentrique rétrospective de cohorte. J Gynecol Obstet Biol Reprod. 2015;44(6):516–23.
Gauchotte E. Frottis cervico-vaginaux pendant la grossesse : évaluation des pratiques professsionnelles et suivi des anomalies. 2011.
Coleridge SL, Wiggans A, Nelissen E, Bethune R, Blackwell R, Bryant A, et al. Improving the uptake of cervical screening in pregnant and recently postnatal women: a quality improvement project. BMJ Open Qual. 2022;11(2):e001709.
Article PubMed PubMed Central Google Scholar
Terlan RJ, Cesar JA. Non-performance of Pap smears among pregnant women in the Extreme South of Brazil: prevalence and associated factors. Cien Saude Colet. 2018;23(11):3557–66.
Nygård M, Daltveit AK, Thoresen SØ, Nygård JF. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study. BMC Health Serv Res. 2007;7(1):10.
留言 (0)